The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis - Wikidata - awgldk - TriplyDB

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

http://www.wikidata.org/entity/Q28546035

about

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model Counting the lives saved by DOTS in India: a model-based approach Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.Understanding the incremental value of novel diagnostic tests for tuberculosis.TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.Primary lytic calvarial tuberculosis: a report of two cases.High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis Tuberculosis

P2860

Q29247878-5A7C875A-9E94-4BF0-8239-3B1674830122 Q30379233-108C1F5E-B295-45F2-B53D-EEAE9D7657BF Q36295833-4AC700B4-5775-4F76-AE19-4B15E5C5DDE6 Q37675764-CE8F97D3-2189-43A0-B534-1438DD0E908F Q39245552-224DC1D6-B683-49B7-BD3B-A0828DA7FB2D Q40245352-D15E419C-A88C-4D7E-91F5-A929189407DF Q42936293-5CBFF3D6-C6DE-47CD-A82C-29BC994088E8 Q47121800-6811C7EF-0724-4382-9C11-728C58972AD4 Q53555490-410F0671-E8A8-4786-BEDA-46D71F6B003F Q58751258-4BE027D1-3DEC-4018-A9F2-11B0A32C04BD Q59200569-E6BE171C-EEA9-4F7D-980E-86CDBF53C2A8

P2860

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

http://www.wikidata.org/entity/Q28546035

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@ast

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@en

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@nl

type

label

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@ast

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@en

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@nl

prefLabel

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@ast

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@en

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@nl

P1433

Q28546035-F5D02413-BBA7-4693-B079-39ABE7311D62

P1476

Q28546035-2A2E7041-47C1-43D2-8CDE-607AF6C3954F

P2093

Q28546035-5DBDD679-335F-4670-B061-00AC5CF94982

Q28546035-A20182C3-FEE4-4BF0-B9BE-6055E44D9E54

Q28546035-BAAED277-C783-4198-9C65-E1A56BE142AF

Q28546035-C55400F1-4705-4D76-A6DA-C58D49ADA9AD

Q28546035-DDBC11F1-486F-41D0-B246-4F789B8D715C

P2860

Q28546035-040BBD3A-A200-49C3-A82B-5D03943B6A54

Q28546035-1A8912D2-5D95-4168-994A-026CAC954EE7

Q28546035-20498B05-F15B-45CF-8B9E-8A5687C1A5DE

Q28546035-26C78437-27F2-4E3D-AE08-A98FEBD4C1E2

Q28546035-2A133840-F5D0-4E6C-A7BF-D9CAC5E7FDF2

Q28546035-2D125891-ACDF-4439-B39C-45F87C953C54

Q28546035-31592E42-09E9-487E-B130-974F524D6760

Q28546035-3AC5B2BB-B2A5-45CB-A76C-306FDBD4343F

Q28546035-3F47CEFB-6AF9-466D-82C2-65407A02D358

Q28546035-4D048623-4AC6-4E20-BD7C-0F7C3172AD2B

P304

Q28546035-DA6CB5DD-BABF-4EAA-84B2-E422D0CCD3E2

P31

Q28546035-7477783E-68A9-4FD5-BFB1-E9ADECE71799

P3181

Q28546035-46FD4B71-314A-4FBA-9D7D-065F4168D070

P356

Q28546035-94914157-53A3-4A31-B2A5-5DA29CCA0FE0

P407

Q28546035-29A261D1-C524-4DBB-B6DA-A9207C491428

P433

Q28546035-AE789108-E5BD-4BF4-A06D-27096937A80B

P478

Q28546035-7A34E30F-840C-4961-8093-5CC3F78DF40F

P50

Q28546035-1270A829-C401-4787-998F-8962E2F549AA

Q28546035-419534BB-322D-4EDA-942A-095FCE35A17F

Q28546035-43BC30CC-E078-4BCE-8085-B1818F98D335

Q28546035-8E0E9AB8-57A0-475F-BF9F-2552155AB188

Q28546035-C8CCFDD7-9FE9-401F-89FE-73B993F60C58

Q28546035-E915A716-AB1B-43BE-AD8F-CF78FEAE4869

P577

Q28546035-0373FEE8-385B-4A09-AFE4-4EE488644B58

P5875

Q28546035-98F04F7B-B5BD-455E-9314-A0F9D95B7C62

P698

Q28546035-F7AA7FF9-212A-497F-BFA8-9D7ACA8288D2

P921

Q28546035-7C80870D-1BFF-446C-A4F1-B0D9FA510FAF

Q28546035-9B083DEE-D1F8-4B99-BD78-5AC5F0999696

Q28546035-AB5CD332-C711-42D6-8221-7F5B65D94EB0

P932

Q28546035-33CD760F-3D07-4D58-B8C5-DC69E58FDE19

P3181

P356

JOURNAL.PONE.0131438

P1433

P1476

The Potential Impact of Up-Fro ...... ti-Drug Resistant Tuberculosis

@en

P2093

Chinnambedu Nainarappan Paramasivan

http://www.w3.org/2001/XMLSchema#string

Nimalan Arinaminpathy

http://www.w3.org/2001/XMLSchema#string

Puneet Dewan

http://www.w3.org/2001/XMLSchema#string

Radhey Shyam Gupta

http://www.w3.org/2001/XMLSchema#string

Sreenivas Achuthan Nair

http://www.w3.org/2001/XMLSchema#string

P2860

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached"

Risk factors for MDR and XDR-TB in a tertiary referral hospital in India

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?

Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India

The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB

Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India

Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature

P304

e0131438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5066707

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0131438

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Shubhangi Kulsange

Catharina Boehme

Kuldeep Singh Sachdeva

Claudia Denkinger

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279731851

http://www.w3.org/2001/XMLSchema#string

P698

26132584

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

4488842

http://www.w3.org/2001/XMLSchema#string